Alvarez-Galovich, Luis
Arana, Estanislao
Blanco Blanco, Juan Francisco
Cancio Trujillo, José Manuel
Castañeda, Santos
de Miguel Benadiba, Carolina
González Ramírez, Alfonso
Martínez Díaz-Guerra, Guillermo
,
Funding for this research was provided by:
Amgen S.A.
UCB Pharma S.A.
Grünenthal Pharma, S.A.
Gedeon Richter Ibérica, S.A.
Theramex Healthcare Spain S.L.
Stryker Iberia S.L.U.
Spineart España S.L.U
Article History
Received: 2 October 2025
Accepted: 3 February 2026
First Online: 16 February 2026
Declarations
:
: Santos Castañeda has received grants or research support from MSD, Pfizer, and UCB Spain. He has also received consulting fees and participated in company-sponsored speaker bureaus for Amgen, Grünenthal Pharma, Eli Lilly, Gedeon-Richter, Janssen, Roche, Sandoz, and UCB Spain, all unrelated to the present manuscript. All the other authors declare that they have no conflicts of interest.